Critical Contrast: Yield10 Bioscience (NASDAQ:YTEN) versus Grown Rogue International (OTCMKTS:GRUSF)

Yield10 Bioscience (NASDAQ:YTEN) and Grown Rogue International (OTCMKTS:GRUSF) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends.

Insider and Institutional Ownership

4.9% of Yield10 Bioscience shares are owned by institutional investors. Comparatively, 9.3% of Grown Rogue International shares are owned by institutional investors. 6.1% of Yield10 Bioscience shares are owned by insiders. Comparatively, 23.2% of Grown Rogue International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Volatility & Risk

Yield10 Bioscience has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, Grown Rogue International has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Yield10 Bioscience and Grown Rogue International, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Yield10 Bioscience	0	2	1	0	2.33
Grown Rogue International	0	0	0	0	N/A

Yield10 Bioscience currently has a consensus price target of $3.50, suggesting a potential upside of 1,370.59%. Given Yield10 Bioscience’s higher possible upside, equities research analysts plainly believe Yield10 Bioscience is more favorable than Grown Rogue International.

Earnings and Valuation

This table compares Yield10 Bioscience and Grown Rogue International’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yield10 Bioscience	$60,000.00	61.34	-$14.45 million	($2.08)	-0.11
Grown Rogue International	$23.35 million	5.55	-$130,000.00	$0.01	65.27

Grown Rogue International has higher revenue and earnings than Yield10 Bioscience. Yield10 Bioscience is trading at a lower price-to-earnings ratio than Grown Rogue International, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Yield10 Bioscience and Grown Rogue International’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Yield10 Bioscience	N/A	-888.81%	-273.34%
Grown Rogue International	-1.70%	-3.71%	-1.67%

Summary

Grown Rogue International beats Yield10 Bioscience on 7 of the 12 factors compared between the two stocks.

About Yield10 Bioscience

Yield10 Bioscience, Inc. operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

About Grown Rogue International

Grown Rogue International Inc., together with its subsidiaries, produces and sells cannabis products in the United States. It offers a range of cultivars for consumers, which are classified as indicas, sativas, and hybrids, as well as provides consulting services. The company sells its products through dispensaries. Grown Rogue International Inc. is headquartered in Medford, Oregon.